1 Erratum to: Drugs (2016) 76(14):1403–1412 DOI 10.1007/s40265-016-0634-8
Page 1404, Section 1.1 Company Agreements
The first sentence, which previously read:
In October 2010, Kyowa Hakko Kirin acquired exclusive licensing rights from Amgen for the development and marketing of brodalumab in Japan and other Asian countries [8].
Should read:
In October 2010, Kyowa Hakko Kirin acquired exclusive licensing rights from Kirin-Amgen for the development and marketing of brodalumab in Japan and other Asian countries [8].
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40265-016-0634-8.
Rights and permissions
About this article
Cite this article
Greig, S.L. Erratum to: Brodalumab: First Global Approval. Drugs 76, 1587 (2016). https://doi.org/10.1007/s40265-016-0647-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-016-0647-3